Macquarie Group Ltd. lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 14,051 shares of the medical equipment provider’s stock after selling 600 shares during the quarter. Macquarie Group Ltd.’s holdings in Intuitive Surgical were worth $14,696,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Stifel Financial Corp increased its position in Intuitive Surgical by 11.2% during the second quarter. Stifel Financial Corp now owns 8,356 shares of the medical equipment provider’s stock worth $7,837,000 after buying an additional 841 shares during the period. Keybank National Association OH increased its position in Intuitive Surgical by 26.7% during the second quarter. Keybank National Association OH now owns 1,322 shares of the medical equipment provider’s stock worth $1,237,000 after buying an additional 279 shares during the period. First Trust Advisors LP increased its position in Intuitive Surgical by 61.4% during the third quarter. First Trust Advisors LP now owns 51,130 shares of the medical equipment provider’s stock worth $53,476,000 after buying an additional 19,458 shares during the period. Davis R M Inc. acquired a new position in Intuitive Surgical during the third quarter worth approximately $219,000. Finally, TIAA CREF Investment Management LLC increased its position in Intuitive Surgical by 9.8% during the second quarter. TIAA CREF Investment Management LLC now owns 449,917 shares of the medical equipment provider’s stock worth $420,839,000 after buying an additional 40,115 shares during the period. Institutional investors and hedge funds own 32.81% of the company’s stock.
In other news, Director Alan J. Levy sold 2,997 shares of the company’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.35, for a total value of $1,112,935.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Craig H. Barratt sold 15,000 shares of the company’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.18, for a total value of $5,567,700.00. Following the completion of the sale, the insider now directly owns 7,500 shares of the company’s stock, valued at approximately $2,783,850. The disclosure for this sale can be found here. Insiders have sold 55,944 shares of company stock valued at $21,432,971 over the last 90 days. 2.20% of the stock is currently owned by insiders.
Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at $369.50 on Wednesday. The company has a market capitalization of $41,452.09, a PE ratio of 48.96, a price-to-earnings-growth ratio of 5.14 and a beta of 0.48. Intuitive Surgical, Inc. has a 12 month low of $203.57 and a 12 month high of $405.05.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.99 by $0.78. The company had revenue of $806.10 million during the quarter, compared to analyst estimates of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The firm’s revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the firm posted $2.06 earnings per share. research analysts forecast that Intuitive Surgical, Inc. will post 7.85 EPS for the current fiscal year.
A number of research firms have recently issued reports on ISRG. Vetr lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $111.83 target price on the stock. in a report on Wednesday, August 16th. Wells Fargo & Company restated a “buy” rating on shares of Intuitive Surgical in a research note on Monday, October 16th. BidaskClub upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Morgan Stanley restated an “overweight” rating on shares of Intuitive Surgical in a research note on Tuesday, September 5th. Finally, Wedbush restated an “outperform” rating and issued a $353.33 price target on shares of Intuitive Surgical in a research note on Monday, September 25th. Five equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $155.78.
Intuitive Surgical Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.